Overview

• Samsung announced an AI feature that analyzes a Galaxy Watch single‑lead ECG to detect Left Ventricular Systolic Dysfunction, a key driver of heart failure.
• The company says the technology completed trials and secured approval from South Korea’s Ministry of Food and Drug Safety.
• The algorithms were built with Medical AI and are based on its 12‑lead ECG models used in more than 100 Korean hospitals serving roughly 120,000 patients each month.
• Samsung says release in other regions will follow additional approvals and characterizes the capability as a first for smartwatches.
• Separately, Samsung is testing an ear‑worn EEG prototype for drowsiness and content‑response monitoring, with potential nonclinical applications still exploratory.